Undertreatment of cardiac risk factors in adolescents with renal failure

Peritoneal Dialysis International

Volumn 21, Issue SUPPL. 3, 2001, Pages

  Querfeld, Uwe ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Cardiovascular disease; End stage renal disease; Mortality; Risk factors

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; PYRIDOXINE;

ADOLESCENT; ANEMIA; ARTICLE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; OBESITY; PERITONEAL DIALYSIS; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK MANAGEMENT; SURVIVAL; UREMIA; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

EID: 0035571699     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102103s50     Document Type: Article

References (28)

1. A survey of 246 suggested coronary risk factors
2. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth
3. Chronic renal failure-a vasculopathic state
4. Cardiac disease in dialysis patients: Diagnosis, burden of disease, prognosis, risk factors and management
5. Role of oxidized low-density lipoprotein in the atherosclerosis of uremia
6. Prospective study of hyper-homocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
7. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
8. C-Reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD
9. Survival on renal replacement therapy: Data from the EDTA Registry
10. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
11. Coronary artery calcifications in children and young adults treated with renal replacement therapy
12. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure
13. Arterial stiffening and vascular calcifications in end-stage renal disease
14. Physiology and biochemistry of endothelial function in children with chronic renal failure
15. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
16. Hypertension in children and adolescents with chronic renal failure and end-stage renal disease
17. Cardiac function and structure in patients with chronic renal failure
18. Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report
19. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease
20. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction
21. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
22. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women
23. Results of recent large cholesterol-lowering trials and implications for clinical management
24. Incidence and risk factors of atherosclerotic cardiovascular accidents in pre-dialysis chronic renal failure patients: A prospective study
25. The increased risk of coronary heart disease associated with nephrotic syndrome
26. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: Lipid lowering and immunosuppression
27. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
28. Effect of high-dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: Results of the Vienna multicenter study